Dysregulated cholesterol regulatory genes as a diagnostic biomarker for cancer.

Seema KuldeepSneha SoniAnubhav SrivastavaAnjali MishraLokendra Kumar SharmaChandi C Mandal

Published in: The journal of gene medicine (2023)

For the first time, the present study identified a gene signature associated with the dysregulation of cholesterol homeostasis in cancer cells that may not only be used as a diagnostic marker, but also comprise a promising drug target for the advancement of cancer therapy.

Keyphrases

cancer therapy
genome wide
low density lipoprotein
papillary thyroid
genome wide identification
squamous cell
emergency department
squamous cell carcinoma
gene expression
genome wide analysis
lymph node metastasis
adverse drug
drug induced